pLV-beta-catenin deltaN90 Citations (6)
Originally described in: Slug and Sox9 cooperatively determine the mammary stem cell state.Guo W, Keckesova Z, Donaher JL, Shibue T, Tischler V, Reinhardt F, Itzkovitz S, Noske A, Zurrer-Hardi U, Bell G, Tam WL, Mani SA, van Oudenaarden A, Weinberg RA Cell. 2012 Mar 2;148(5):1015-28. PubMed Journal
Articles Citing pLV-beta-catenin deltaN90
| Articles |
|---|
| Synthetic Lethality of Wnt Pathway Activation and Asparaginase in Drug-Resistant Acute Leukemias. Hinze L, Pfirrmann M, Karim S, Degar J, McGuckin C, Vinjamur D, Sacher J, Stevenson KE, Neuberg DS, Orellana E, Stanulla M, Gregory RI, Bauer DE, Wagner FF, Stegmaier K, Gutierrez A. Cancer Cell. 2019 Apr 15;35(4):664-676.e7. doi: 10.1016/j.ccell.2019.03.004. PubMed |
Luminescent and fluorescent triple reporter plasmid constructs for Wnt, Hedgehog and Notch pathway.
Maier J, Elmenofi S, Taschauer A, Anton M, Sami H, Ogris M.
PLoS One. 2019 Dec 20;14(12):e0226570. doi: 10.1371/journal.pone.0226570. eCollection 2019.
PubMed
Associated Plasmids |
| Lats1/2 Sustain Intestinal Stem Cells and Wnt Activation through TEAD-Dependent and Independent Transcription. Li Q, Sun Y, Jarugumilli GK, Liu S, Dang K, Cotton JL, Xiol J, Chan PY, DeRan M, Ma L, Li R, Zhu LJ, Li JH, Leiter AB, Ip YT, Camargo FD, Luo X, Johnson RL, Wu X, Mao J. Cell Stem Cell. 2020 May 7;26(5):675-692.e8. doi: 10.1016/j.stem.2020.03.002. Epub 2020 Apr 6. PubMed |
| Wnt/beta-Catenin Inhibition Disrupts Carboplatin Resistance in Isogenic Models of Triple-Negative Breast Cancer. Abreu de Oliveira WA, Moens S, El Laithy Y, van der Veer BK, Athanasouli P, Cortesi EE, Baietti MF, Koh KP, Ventura JJ, Amant F, Annibali D, Lluis F. Front Oncol. 2021 Jul 22;11:705384. doi: 10.3389/fonc.2021.705384. eCollection 2021. PubMed |
| Human Erbb2-induced Erk activity robustly stimulates cycling and functional remodeling of rat and human cardiomyocytes. Strash N, DeLuca S, Janer Carattini GL, Heo SC, Gorsuch R, Bursac N. Elife. 2021 Oct 19;10. pii: 65512. doi: 10.7554/eLife.65512. PubMed |
| ATP6AP2, a regulator of LRP6/beta-catenin protein trafficking, promotes Wnt/beta-catenin signaling and bone formation in a cell type dependent manner. Xiong L, Guo HH, Pan JX, Ren X, Lee D, Chen L, Mei L, Xiong WC. Bone Res. 2024 May 29;12(1):33. doi: 10.1038/s41413-024-00335-7. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.